$8.21
arrow_drop_down0.72%There's no data available for key stats
There's no data available for ratios/profitability stats
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer
Here's Why You May Invest in Theravance (TBPH) Stock Now
Wall Street Analysts Predict a 90.53% Upside in Theravance Bio (TBPH): Here's What You Should Know
Theravance Bio (TBPH) Down 6.1% Since Last Earnings Report: Can It Rebound?
Theravance (TBPH) Q1 Earnings Top, Revenues Match Estimates
Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates